Research analysts at SunTrust Banks Inc. assumed coverage on shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) in a research note issued to investors on Thursday, The Fly reports. The brokerage set a “buy” rating on the stock.

Other research analysts have also issued research reports about the company. B. Riley assumed coverage on Ekso Bionics Holdings in a research report on Wednesday, September 21st. They set a “buy” rating and a $8.00 price objective for the company. Zacks Investment Research lowered Ekso Bionics Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, August 2nd. Finally, Rodman & Renshaw restated a “buy” rating on shares of Ekso Bionics Holdings in a research report on Sunday, July 31st.

Shares of Ekso Bionics Holdings (NASDAQ:EKSO) traded down 2.58% on Thursday, reaching $6.05. The company had a trading volume of 390,403 shares. The stock’s 50 day moving average is $4.31 and its 200 day moving average is $5.40. Ekso Bionics Holdings has a 52 week low of $3.45 and a 52 week high of $10.08. The firm’s market capitalization is $99.41 million.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Ekso Bionics Holdings (NASDAQ:EKSO) last issued its quarterly earnings results on Thursday, July 28th. The company reported ($0.61) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.28) by $0.33. On average, equities analysts anticipate that Ekso Bionics Holdings will post ($1.74) EPS for the current year.

5 Day Chart for NASDAQ:EKSO

The Fly

Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with's FREE daily email newsletter.